Paolo Morgese is the EU Director of Market Access & Member Relations at the Alliance for Regenerative Medicine (Geneva, Switzerland). In addition to this role, Morgese also serves as the Managing Director of Forethought Access (Geneva, Switzerland).
Prior to joining the Alliance for Regenerative Medicine, Morgese held senior market access leadership positions, including his serving as Director of EU Research and Market Access at Deerfield Management (Lausanne, Switzerland), and Associate Director of Market Access at Merck Serono (Eysins, Switzerland).
Morgese’s interest centre around health technology and value assessment, particularity in early stages of product development, EU and international policy debates around access to cell and gene therapies, and value-based contracting.
Morgese holds a Bachelor of Science in Economics and a Master of Science in Financial and Business Economics.